Drug Pipeline

Atropine Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
2
Recruiting
1
Phase 3
4
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-05 NCT07095894
A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control		 Recruitment opened
2026-05-28 NCT07095894
A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control		 Trial sites expanded: 0 -> 12 locations
Active Studies by Phase
Phase 4
1
Phase 3
1
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07434635 APPRAISE: Assessment of Pain and Posterior Synechiae Reduction With Atropine, an… Eye Disorders Recruiting
Phase 3
NCT07095894 A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control Myopia Recruiting
Phase 2
NCT06579287 A Study of SHJ002 Sterile Ophthalmic Solution for Myopia Control Myopia, Progressive Active, Not Recruiting
NCT07367178 Study of Sacituzumab Govitecan With Atropine to Improve Tolerability in Advanced TNBC and… Breast Cancer Not Yet Recruiting
Sponsors Running Atropine Trials
Sunhawk Vision Biotech, Inc. (1) Jaeb Center for Health Research (1) MedSIR (1) University of California, San Francisco (1)
Disease Areas
Breast Cancer (1) Triple-Negative Breast Cancer (1)
Get alerts when Atropine trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free